Don’t get too excited, investors: GSK has no near-term plans for consumer health spinoff

Carly Helfand

Let GlaxoSmithKline be clear: It's open to spinning off its healthcare division at some nebulous point in the future. But it's not happening anytime soon.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS